Loading patent…
AssigneesMerial Limited, The Queen's University of Belfast, University of Saskatchewan
InventorsGordon Allan, Brian Meehan, Edward Clark, John Ellis, Deborah Haines, Lori Hassard, John Harding, Catherine Elisabeth Charreyre, Gilles Emile Chappuis, Francis McNeilly
Estimating the term…
The invention relates to new porcine circovirus strains isolated from pulmonary or ganglionic samples obtained from farms affected by the post-weaning multisystemic wasting syndrome (PMWS). It relates to purified preparations of these strains, conventional attenuated or inactivated vaccines, recombinant live vaccines, plasmid vaccines and subunit vaccines, as well as reagents and diagnostic methods. It also relates to the DNA fragments which can be used for the production of subunits in an in vitro expression vector or as sequences to be integrated into a virus or plasmid type in vivo expression vector.
A vector comprising an isolated DNA molecule comprising a sequence selected from the group consisting of SEQ ID NO:
A vector comprising an isolated DNA molecule comprising a sequence selected from the group consisting of ORFs 1 to 13 of porcine circovirus type II.
The vector of any one claims 38-48 wherein the vector is a virus.
An isolated DNA molecule comprising a sequence selected from the group consisting of SEQ ID NO:
An isolated DNA molecule comprising a nucleotide sequence encoding an epitope which is specific to PCV-2 and not specific to PCV-1.
Dependencies are inferred from the claim text.